Monsanto (NYSE:MON) has earned a consensus recommendation of “Hold” from the seventeen analysts that are covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $125.94.
A number of research firms recently weighed in on MON. Argus lowered shares of Monsanto from a “buy” rating to a “sell” rating in a report on Monday, April 16th. ValuEngine lowered shares of Monsanto from a “buy” rating to a “hold” rating in a report on Wednesday, May 2nd. BMO Capital Markets lowered shares of Monsanto from an “outperform” rating to a “market perform” rating in a report on Tuesday, April 10th. Sanford C. Bernstein restated a “neutral” rating and issued a $119.00 target price on shares of Monsanto in a report on Monday, April 9th. Finally, Zacks Investment Research lowered shares of Monsanto from a “hold” rating to a “sell” rating in a report on Monday, April 9th.
Hedge funds have recently modified their holdings of the business. Gradient Investments LLC bought a new position in shares of Monsanto during the 4th quarter valued at approximately $108,000. Bruderman Asset Management LLC bought a new position in shares of Monsanto during the 1st quarter valued at approximately $114,000. Private Capital Group LLC grew its position in shares of Monsanto by 1,663.4% during the 1st quarter. Private Capital Group LLC now owns 1,252 shares of the basic materials company’s stock valued at $146,000 after acquiring an additional 1,181 shares during the period. Elkfork Partners LLC bought a new position in shares of Monsanto during the 4th quarter valued at approximately $162,000. Finally, Truewealth LLC bought a new position in shares of Monsanto during the 4th quarter valued at approximately $163,000. 74.99% of the stock is owned by institutional investors and hedge funds.
Monsanto (NYSE:MON) last posted its earnings results on Thursday, April 5th. The basic materials company reported $3.22 earnings per share for the quarter, missing the Zacks’ consensus estimate of $3.31 by ($0.09). Monsanto had a return on equity of 37.31% and a net margin of 17.07%. The business had revenue of $5.02 billion during the quarter, compared to analyst estimates of $5.34 billion. During the same quarter in the prior year, the company earned $3.19 EPS. The company’s revenue was down 1.1% on a year-over-year basis. research analysts predict that Monsanto will post 5.7 EPS for the current year.
Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds under the DEKALB, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.